In fact, clinical studies have demonstrated peripheral blood BDNF levels were downregulated in patients with MDD and it is a potential biomarker to inform the treatment response (Molendijk et al., 2014; Peng et al., 2018). Here, BDNF is linked to major depressive disorder.